Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by Magnetar Financial LLC

Magnetar Financial LLC boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 32.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 510,610 shares of the company’s stock after acquiring an additional 124,152 shares during the quarter. Magnetar Financial LLC owned about 0.40% of Henry Schein worth $32,730,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of HSIC. Swedbank AB bought a new stake in Henry Schein during the first quarter worth approximately $215,998,000. Thompson Siegel & Walmsley LLC acquired a new stake in Henry Schein during the 2nd quarter worth about $46,683,000. Nuance Investments LLC boosted its holdings in shares of Henry Schein by 28.5% in the first quarter. Nuance Investments LLC now owns 1,755,190 shares of the company’s stock worth $132,552,000 after buying an additional 388,843 shares during the period. Fiduciary Management Inc. WI increased its position in shares of Henry Schein by 17.1% in the fourth quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock worth $172,947,000 after acquiring an additional 333,855 shares in the last quarter. Finally, KBC Group NV raised its holdings in shares of Henry Schein by 163.5% during the fourth quarter. KBC Group NV now owns 521,964 shares of the company’s stock valued at $39,518,000 after acquiring an additional 323,901 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Trading Down 1.9 %

Shares of NASDAQ:HSIC opened at $71.15 on Monday. Henry Schein, Inc. has a 52-week low of $60.01 and a 52-week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. The company has a market cap of $9.11 billion, a P/E ratio of 24.04, a P/E/G ratio of 1.88 and a beta of 0.86. The stock’s 50-day moving average is $69.89 and its 200-day moving average is $70.31.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. During the same quarter in the prior year, the business earned $1.31 earnings per share. The firm’s revenue for the quarter was up .0% on a year-over-year basis. Equities research analysts predict that Henry Schein, Inc. will post 4.75 earnings per share for the current year.

Insiders Place Their Bets

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 1.14% of the company’s stock.

Wall Street Analyst Weigh In

HSIC has been the topic of several research analyst reports. Robert W. Baird lowered their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. Barrington Research reissued an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a research report on Friday. Piper Sandler restated an “overweight” rating and set a $86.00 price objective on shares of Henry Schein in a research report on Friday, June 21st. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Finally, UBS Group lowered their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $77.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.